Laboratory Corporation of America Holdings
NYSE:LH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
191.8992
246.22
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Laboratory Corporation of America Holdings
Wall Street
Price Targets
LH Price Targets Summary
Laboratory Corporation of America Holdings
According to Wall Street analysts, the average 1-year price target for
LH
is 270.78 USD
with a low forecast of 233.31 USD and a high forecast of 307.65 USD.
LH Last Price Targets
Laboratory Corporation of America Holdings
The latest public price target was made on Sep 24, 2024 by
Elizabeth Anderson
from
Evercore ISI
,
who expects
LH
stock to
rise by 4%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Elizabeth Anderson
Evercore ISI
|
240
USD
Upside 4% |
3 months ago
Sep 24, 2024
|
Labcorp price target lowered to $240 from $250 at Evercore ISI
TheFly
|
Brian Tanquilut
Jefferies
|
265
USD
Upside 15% |
3 months ago
Sep 23, 2024
|
Laboratory Corporation of America (LH) PT Raised to $265 at Jefferies
StreetInsider
|
Michael Ryskin
Bank of America Securities
|
260
USD
Upside 13% |
4 months ago
Aug 5, 2024
|
Labcorp price target raised to $260 from $240 at BofA
TheFly
|
Eric Coldwell
Robert W. Baird
|
277
USD
Upside 20% |
4 months ago
Aug 2, 2024
|
LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings
Benzinga
|
Stephanie Davis
Barclays
|
249
USD
Upside 8% |
4 months ago
Aug 2, 2024
|
LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings
Benzinga
|
David Toung
Argus Research
|
250
USD
Upside 8% |
9 months ago
Mar 25, 2024
|
Argus Upgrades Laboratory Corporation of America (LH) to Buy on stronger top-line growth and margin expansion
StreetInsider
|
Price Targets
Revenue
Forecast
Revenue Estimate
Laboratory Corporation of America Holdings
For the last 8 years the
compound annual growth rate for
Laboratory Corporation of America Holdings's revenue is
4%.
The projected
CAGR
for the next 4 years is
6%.
Operating Income
Forecast
Operating Income Estimate
Laboratory Corporation of America Holdings
For the last 8 years the
compound annual growth rate for
Laboratory Corporation of America Holdings's operating income is
0%.
The projected
CAGR
for the next 3 years is
25%.
Net Income
Forecast
Net Income Estimate
Laboratory Corporation of America Holdings
For the last 8 years the
compound annual growth rate for
Laboratory Corporation of America Holdings's net income is
-1%.
The projected
CAGR
for the next 4 years is
41%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LH's stock price target?
Price Target
270.78
USD
According to Wall Street analysts, the average 1-year price target for
LH
is 270.78 USD
with a low forecast of 233.31 USD and a high forecast of 307.65 USD.
What is Laboratory Corporation of America Holdings's Revenue forecast?
Projected CAGR
6%
For the last 8 years the
compound annual growth rate for
Laboratory Corporation of America Holdings's revenue is
4%.
The projected
CAGR
for the next 4 years is
6%.
What is Laboratory Corporation of America Holdings's Operating Income forecast?
Projected CAGR
25%
For the last 8 years the
compound annual growth rate for
Laboratory Corporation of America Holdings's operating income is
0%.
The projected
CAGR
for the next 3 years is
25%.
What is Laboratory Corporation of America Holdings's Net Income forecast?
Projected CAGR
41%
For the last 8 years the
compound annual growth rate for
Laboratory Corporation of America Holdings's net income is
-1%.
The projected
CAGR
for the next 4 years is
41%.
You don't have any saved screeners yet
